Cargando…
Glycogen Synthase Kinase 3 (GSK3) Inhibitor, SB-216763, Promotes Pluripotency in Mouse Embryonic Stem Cells
Canonical Wnt/β-catenin signaling has been suggested to promote self-renewal of pluripotent mouse and human embryonic stem cells. Here, we show that SB-216763, a glycogen synthase kinase-3 (GSK3) inhibitor, can maintain mouse embryonic stem cells (mESCs) in a pluripotent state in the absence of exog...
Autores principales: | Kirby, Leslie A., Schott, Jason T., Noble, Brenda L., Mendez, Daniel C., Caseley, Paul S., Peterson, Sarah C., Routledge, Tyler J., Patel, Nilay V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383737/ https://www.ncbi.nlm.nih.gov/pubmed/22745733 http://dx.doi.org/10.1371/journal.pone.0039329 |
Ejemplares similares
-
Glycogen synthase kinase-3β inhibitor SB216763 promotes DNA repair in ischemic retinal neurons
por: Zhang, Jing, et al.
Publicado: (2020) -
Corrigendum: Glycogen synthase kinase-3β inhibitor SB216763 promotes DNA repair in ischemic retinal neurons
Publicado: (2021) -
Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice
por: Ma, Xian-Cang, et al.
Publicado: (2013) -
Lenticular mitoprotection. Part A: Monitoring mitochondrial depolarization with JC-1 and artifactual fluorescence by the glycogen synthase kinase-3β inhibitor, SB216763
por: Brooks, Morgan M., et al.
Publicado: (2013) -
Testing Fmr1(KO) Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127
por: Westmark, Pamela R., et al.
Publicado: (2021)